FDA initiatives to support dose optimization in oncology drug development: the less may be the better
Transl Clin Pharmacol
.
2022 Jun;30(2):71-74.
doi: 10.12793/tcp.2022.30.e9.
Epub 2022 Jun 22.
Author
Hanlim Moon
1
Affiliation
1
Medirama, Seoul 06927, Korea.
PMID:
35800667
PMCID:
PMC9253446
DOI:
10.12793/tcp.2022.30.e9
No abstract available